In this sense, we remark the association described between the LDLR expression and the abnormal lipidic metabolism as a factor of cancer progression and recurrence in hepatocellular carcinoma, lung cancer, breast cancer, colorectal cancer and prostate cancer [5,18]. Here, LDLR is linked to breast carcinoma.